Navigation Links
Novis Pharmaceuticals Hires Lisa Lopez

Human Resources Professional Brings Diverse Expertise

MIAMI, Dec. 9 /PRNewswire/ -- Novis Pharmaceuticals, a leading distributor of biotherapeutic products to healthcare providers, is pleased to announce that Lisa Lopez has joined the company as Vice President of Human Resources. Ms. Lopez was most recently Human Resources Director at Cordis Corporation, a Johnson & Johnson Company. Her 17-year career began in Human Resources shortly after graduating from Florida International University (FIU). She has held various Human Resources roles of increasing responsibilities at Siemens, The Dow Chemical Company and Ryder Systems, Inc. Ms. Lopez also earned an MBA from FIU.

Tom Burke, President and CEO of Novis Pharmaceuticals, said, "Lisa brings a diverse background in Human Resources including recruitment, compensation, benefits, talent development, employee retention, training, and compliance. We have aggressive growth goals and a commitment to our customers to provide industry-leading standards of excellence. We know it is the quality of our people that defines who we are as an organization and Lisa's expertise will be invaluable to our future success."

"I am excited to join Novis Pharmaceuticals," added Ms. Lopez. "I have been impressed with the people and their passion for healthcare and delivering extraordinary service to our customers and partners. I look forward to helping build the Novis Pharmaceuticals of the future by acquiring, developing and retaining the top talent in the industry."

For more information about Novis Pharmaceuticals, please visit

About NOVIS Pharmaceuticals

Novis Pharmaceuticals is a leading national distributor of some of the world's leading plasma-derived products such as albumin, immune globulin, hyperimmunes and anti-hemophilic Factors VII, VIII and IX. Hospitals, home infusion therapy companies and other healthcare providers use these biotherapeutics to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions.

SOURCE Novis Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Renovis Announces Management Changes
2. Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link
3. Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: